Building Pharma Campaigns That Earn Trust Not Just Reach
The modern health media landscape overwhelms both patients and healthcare professionals (HCPs) with a steady stream of contradictory information. Even when content is compliant,...
Fair Balance Isn’t Enough: Why Your DTC Ads May Still Trigger FDA Action
In today’s regulatory landscape, simply meeting fair balance requirements doesn’t guarantee your ad will pass muster. As the FDA intensifies scrutiny of direct-to-consumer (DTC)...
The AI Tools No One’s Watching: How Shadow Tech Is Creeping into Pharma Marketing
In an era defined by rapid digital transformation, AI tools in pharma marketing are shifting from innovation to necessity. But not all AI adoption...
When AI Picks Your Media Plan: How Pharma Marketers Can Stay in Control
Artificial intelligence is no longer just a buzzword—it's a force reshaping how pharmaceutical brands plan, execute, and optimize omnichannel marketing. But when AI systems...
Pricing Stories for the C‑Suite: A Pharma Strategy for Boards, Analysts, and Regulators
Drug pricing is no longer just a detail on a payer slide—it’s a headline issue in boardrooms, on earnings calls, and across regulatory hearings....
Training Marketers for Everyday AI: Building Literacy and Risk Awareness Inside Pharma Teams
AI training for pharma marketers is quickly becoming a critical capability rather than a nice-to-have. As artificial intelligence becomes embedded in everyday platforms—from email...
Rethinking APAC: An AI and Data‑First Pharma Marketing Strategy for the Region
Creating an effective APAC pharma marketing strategy has never been more complex—or more crucial. With vast differences in privacy laws, digital maturity,...
Turning 2026 Pharma Conferences Into Campaign Fuel: A Smarter Marketing Strategy for Events
Pharma conferences brim with insights, new faces, and fresh ideas, yet most organizations struggle to turn that energy into sustained post-event momentum. A well-defined...
Oral GLP‑1s and the Next Chapter of Obesity Care: Rethinking Your Pharma Marketing Strategy
As oral GLP‑1 drugs make their debut alongside established injectables, the conversation around obesity and type 2 diabetes is rapidly evolving. It’s no longer...
From ESG Reports to Real Messages: Making Sustainable Pharma Marketing Credible
Sustainable pharma marketing is gaining traction across the healthcare industry. But there's a gap between what companies are doing and what they’re saying. While...
